日本語 
Elevate Holistics has introduced a telehealth service that allows patients to receive low-dose ketamine care from home. This new service expands the companys offerings to include ketamine treatment that is…
NTT Technocross unveils HM-neo academic healthcare tool
NTT Technocross Corporation will begin offering "HM-neo academic," a university-optimized version of…
Doctors Prime Secures ¥420M Debt Financing from Banks
Doctors Prime Co., Ltd. has completed its Series A round with loans…
Ubie Enhances AI Capabilities Through Mayo Clinic Platform_Accelerate Program
Ubie Inc. aims to 'use technology to guide people to appropriate medical…
Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics
PHC Holdings Corporation and its subsidiary Ascensia Diabetes Care, a global diabetes…
Eisai seeks FDA approval for LEQEMBI Subcutaneous dose
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Hitachi and Partners build generative AI healthcare platform
Hitachi Systems, Ltd., Kanagawa Prefecture, MedMirai Co., Ltd., and the University of…
Eisai’s Tazemetostat Approved as Orphan Drug in Japan
Eisai Co., Ltd. announced that it has received orphan drug designation for…
NTT Technocross unveils HM-neo academic healthcare tool
NTT Technocross Corporation will begin offering "HM-neo academic," a university-optimized version of…
Doctors Prime Secures ¥420M Debt Financing from Banks
Doctors Prime Co., Ltd. has completed its Series A round with loans…
Ubie Enhances AI Capabilities Through Mayo Clinic Platform_Accelerate Program
Ubie Inc. aims to 'use technology to guide people to appropriate medical…
Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics
PHC Holdings Corporation and its subsidiary Ascensia Diabetes Care, a global diabetes…
Eisai seeks FDA approval for LEQEMBI Subcutaneous dose
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Hitachi and Partners build generative AI healthcare platform
Hitachi Systems, Ltd., Kanagawa Prefecture, MedMirai Co., Ltd., and the University of…
Eisai’s Tazemetostat Approved as Orphan Drug in Japan
Eisai Co., Ltd. announced that it has received orphan drug designation for…
English